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Abstract
Introduction Tacrolimus is an important immunosuppressive
drug for organ transplantation patients. It has a narrow
therapeutic range, toxic side effects, and a blood concentration
with wide intra- and interindividual variability. Hence, it is of the
utmost importance to monitor tacrolimus blood concentration,
thereby ensuring clinical effect and avoiding toxic side effects.
Prediction models for tacrolimus blood concentration can
improve clinical care by optimizing monitoring of these
concentrations, especially in the initial phase after
transplantation during intensive care unit (ICU) stay. This is the
first study in the ICU in which support vector machines, as a new
data modeling technique, are investigated and tested in their
prediction capabilities of tacrolimus blood concentration. Linear
support vector regression (SVR) and nonlinear radial basis
function (RBF) SVR are compared with multiple linear
regression (MLR).
Methods Tacrolimus blood concentrations, together with 35
other relevant variables from 50 liver transplantation patients,
were extracted from our ICU database. This resulted in a dataset
of 457 blood samples, on average between 9 and 10 samples
per patient, finally resulting in a database of more than 16,000
data values. Nonlinear RBF SVR, linear SVR, and MLR were
performed after selection of clinically relevant input variables
and model parameters. Differences between observed and
predicted tacrolimus blood concentrations were calculated.
Prediction accuracy of the three methods was compared after
fivefold cross-validation (Friedman test and Wilcoxon signed
rank analysis).
Results Linear SVR and nonlinear RBF SVR had mean absolute
differences between observed and predicted tacrolimus blood
concentrations of 2.31 ng/ml (standard deviation [SD] 2.47)
and 2.38 ng/ml (SD 2.49), respectively. MLR had a mean
absolute difference of 2.73 ng/ml (SD 3.79). The difference
between linear SVR and MLR was statistically significant (p <
0.001). RBF SVR had the advantage of requiring only 2 input
variables to perform this prediction in comparison to 15 and 16
variables needed by linear SVR and MLR, respectively. This is an
indication of the superior prediction capability of nonlinear SVR.
Conclusion Prediction of tacrolimus blood concentration with
linear and nonlinear SVR was excellent, and accuracy was
superior in comparison with an MLR model.
Introduction
Purpose
Tacrolimus blood concentrations demonstrate a wide intra-
and interindividual variability. Therefore, monitoring of these
concentrations remains an issue of pivotal importance to
safeguard therapeutic efficacy and to manage the risk for
nephrotoxicity, other toxicities, and rejection in liver transplan-
tation patients [1]. This study examines the feasibility and clin-
ical benefits of using a support vector regression (SVR)
algorithm in comparison with a multiple linear regression
AI = artificial intelligence; ALKPHOS = alkaline phosphatise; ALT = alanine aminotransferase; ANN = artificial neural network; AST = aspartate ami-
notransferase; CR = serum creatinine; GGT = gamma-glutamyl transpeptidase; Hct = hematocrit; ICU = intensive care unit; LDH = lactate dehydro-
genase; MLR = multiple linear regression; RBF = radial basis function; RBF SVR = radial basis function support vector regression (nonlinear support 
vector regression); SD = standard deviation; SVM = support vector machine; SVR = support vector regression; UR = urea.Critical Care    Vol 11 No 4    Van Looy et al.
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(MLR) algorithm in predicting tacrolimus blood concentration.
Tacrolimus blood concentration is predicted starting from a
selected number of clinically relevant input variables.
Background
Hospital information systems in intensive care medicine gener-
ate large datasets on a daily basis. These rapidly increasing
amounts of data make the task of extracting correct and rele-
vant clinical information from intensive care unit (ICU) patients
difficult [2,3]. Data modeling techniques based on machine
learning such as support vector machines (SVMs) can partially
reduce workload, aid clinical decision-making, and lower the
frequency of human error [4]. Fundamental research in clinical
data modeling forms the basis on which later validation can be
performed in multicentered clinical trials. This is the first study
to use SVM for data modeling in the ICU domain. SVMs have
been applied, however, in molecular biology [5-7], bioinformat-
ics [8], as well as in genetics [9] and proteomics [10,11]. In
cancer research, kernel methods (or SVM) have been used to
predict malignancy in brain tumors [12,13] and also in staging
certain forms of breast and prostate cancer [14,15]. In cardi-
ology, heart valve disease has been predicted with SVMs, and
in fundamental cardiology research, nucleotide polymor-
phisms of candidate genes for ischemic heart disease have
been modeled by kernel methods [16,17]. Clinical decision-
making has been compared for prospective performance with
logistic regression and SVM [18]. In contrast with the absence
of data concerning SVM applications in the ICU, artificial neu-
ral networks (ANNs) – as a less recent statistical learning tech-
nique – have been studied thoroughly in the ICU environment:
they have been used for prediction of ICU mortality and prog-
nosis in septic shock [19,20], clinical decision-making [21],
and prediction of plasma drug concentrations [22]. Also, the
management of infectious diseases [23], real-time analysis of
hemodynamics [24], and research in cardiology [25,26] and
oncology [27,28] have benefited from recent evolutions in arti-
ficial intelligence (AI) and ANN.
Underlying theory
The roots of SVM lie in the statistical learning theory [29],
which describes properties of learning machines which enable
them to generalize well to unseen data. During the 1990s,
SVM was developed by Vapnik and coworkers [30-32] at Bell
Labs (formerly AT&T Bell Laboratories, Murray Hill, NJ, USA).
A profound overview of the underlying theory and the SVM
algorithm itself is given by Guyon and Elisseeff [33]. In the
case of SVR [29], the goal is to find a function that predicts
the target values of the training data with a deviation of at most
ε, while requiring this function to be as flat as possible. The
core of the support vector algorithm does this for linear func-
tions f(x) = <w,x> + b, where (w,x) denotes the dot product of
vectors w and x, thereby enforcing flatness by minimizing |w|
(|w| denotes the Euclidian norm of vector w). By using a dual
representation of the minimization problem, the algorithm
requires only dot products of the input patterns. This allows
the application of nonlinear regression by using a kernel func-
tion [34] that represents the dot product of the two trans-
formed vectors. The MLR and the linear support vector
algorithm are both linear approaches, but they differ in their
underlying theoretical heuristics: the MLR method fits a model
using the least-mean-squares heuristic (that is, the sum of the
squared distances to the regression line is minimized). The
support vector algorithm fits a flat-as-possible function by
searching a separating hyperplane (Figure 1). The radial basis
function (RBF) SVR method fits a nonlinear function onto the
data, again aiming for maximum flatness. The RBF kernel is
also often named a Gaussian kernel since the kernel function
is the same as the Gaussian distribution function. Smola and
Schölkopf [35] give an excellent overview of many details of
the SVR procedure.
Materials and methods
Data
This study received approval from the Ethics Committee of
Ghent University Hospital. Fifty patients who had recently
undergone liver transplantation in Ghent University Hospital
were included, and their medical records were reviewed. Tac-
rolimus blood concentrations, together with 35 other clinically
relevant variables, were extracted from the ICU database. The
following input variables were considered to influence tac-
rolimus blood concentration and were included: gender, age,
weight, number of transplantations, number of days after sur-
gery, existence of renal dysfunction (serum creatinine [CR]
and urea [UR]) or liver dysfunction (alanine aminotransferase
[ALT], aspartate aminotransferase [AST], gamma-glutamyl
transpeptidase [GGT], total and conjugated bilirubin, alkaline
phosphatise [ALKPHOS], and lactate dehydrogenase [LDH]
levels), hematocrit (Hct), albumin, glucose, cholesterol, and six
Figure 1
The support vector algorithm heuristic The support vector algorithm heuristic. In support vector machines, 
classification of datapoints or prediction of an outcome parameter is 
done by finding the 'hyperplane' that separates the datapoints by trans-
forming the input variable dataset by a mathematical function into a 
'higher dimension' in which separation is much easier (feature map = 
input variables dataset). The basis of this new heuristic is that classifi-
cation of a seemingly chaotic input space is possible when one 
increases dimensionality and thereby finds a separating plane. Copy-
right permission from V.P. Bioinformatics (Improved Outcomes Soft-
ware, Kingston, ON, Canada).Available online http://ccforum.com/content/11/4/R83
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doses of tacrolimus, namely the dose at 8 a.m. and 8 p.m. from
the three days (day 1, day 2, and day 3) before the day of the
measured tacrolimus blood concentration (day 0). Coadminis-
tered medications were not included. Variables cholesterol
and albumin were omitted due to too great a percentage of
missing data (greater than 99%) (caused by not measuring
these variables on a daily basis). The data were reorganized in
patient days in which each record contained the following var-
iables: gender, weight, age, days since transplantation, the 12
previously mentioned biochemical variables measured on day
0, the same parameters on day 1, tacrolimus blood concentra-
tion on day 1, the last six tacrolimus doses given, and the tac-
rolimus blood concentration on day 0 as a prediction target.
This resulted in a total amount of 35 input variables and 1 out-
put variable. Records in which the output parameter was miss-
ing were removed from the data. Patient days in which less
than four of the six previous doses were available were also left
out. This resulted in 457 records originating from 50 patients
and a total of more than 16,000 data values. In these 457
records, 77% were complete, 15% contained a single missing
value, and the remaining 7% had a maximum of 3 (of 35) val-
ues missing. This resulted in a total of 147/15,995 (0.92%)
missing values. This extremely low number of missing values
was filled in by means of an expectation maximization method
[36].
Data analysis
Data analysis for the linear SVR and the RBF SVR model was
performed using software implemented by the authors based
on the libSVM 2.82 [37] software package. Analysis for the
MLR model was performed in SPSS 12.0 (SPSS Inc., Chi-
cago, IL, USA). A mean absolute difference with the measured
tacrolimus blood concentration of maximum 3 ng/ml and a
standard deviation (SD) of maximum 5 ng/ml was agreed upon
to be acceptable by expert opinion.
Variable selection for the linear SVR and the RBF SVR 
model
This phase in the SVR model building is analogous with the
variable selection phase for the MLR model. Using all 35 vari-
ables to construct a data model would result in suboptimal
accuracy because different variables may contain overlapping
information that disturbs the model-constructing process.
Therefore, for each method (linear SVR, RBF SVR, and MLR),
variable selection out of this total of 35 variables was done
using recursive addition, recursive removal, stepwise addition,
and stepwise removal of the input variables. These selection
procedures are inspired by the commonly used stepwise
regression technique in MLR, first presented by Effroymson
[38]. The four selection procedures often result in different var-
iable subsets. The best-performing subset was selected. In lin-
ear SVR, 15 features were selected: weight, age, days since
transplantation, Hct, UR, ALKPHOS, ALT, total bilirubin, GGT
(all on day 0), LDH on day 1, UR on day 1, morning doses of
tacrolimus on day 2 and day 3, evening dose of tacrolimus on
day 1, and the tacrolimus concentration on day 1. For RBF
SVR, only two features sufficed: tacrolimus blood concentra-
tion on day 1 and the evening dose of tacrolimus on day 1. To
validate a specific variable selection in linear SVR and RBF
SVR, fivefold cross-validation was used. In this process, the
available data are split into five equally sized parts. The remain-
der of the procedure is repeated five times. In each iteration, a
different one of the five parts is kept apart, while the remaining
four parts are used to construct the data model. The part that
was kept separate is then used to verify the data model. The
reported accuracy is the total of those measured in each of the
five iterations, thus covering the total amount of available data.
Variable selection for the MLR model
In the MLR model also, the variable selection was performed
with a forward, a backward, and a stepwise algorithm for sim-
ple linear regression in SPSS 12.0 and regression coefficients
were checked for significance. The significance level was set
at α = 0.05. Adjusted R2 values and goodness of fit were com-
pared for the different MLR variable selections in SPSS. After
selection of the final variable set for MLR, these variables were
tested for correlation and multicollinearity. Variance inflation
factor and eigenvalues were determined. For MLR, 16 varia-
bles were retained: gender, weight, age, Hct, LDH, UR, ALK-
PHOS, GGT, CR (all on day 0), AST on day 1, ALT on day 1,
morning and evening doses of tacrolimus on day 1, evening
dose of tacrolimus on day 2, and the morning dose of tac-
rolimus on day 3. Gender, weight, and age were included
because of their clinical relevancy. After linear regression of
this final variable set, normality testing of the residues as well
as heteroscedasticity testing were performed. After searching
the lambda value for the maximum likelihood with the Box-Cox
algorithm, a transformation of the dependent variable (tac-
rolimus blood concentration) in the MLR model was performed
because of heteroscedasticity of the residuals. To validate the
final regression model, fivefold cross-validation was used, as in
the SVR model.
Parameter selection for the linear SVR and the RBF SVR 
model
Parameter selection denotes the process of setting data
model parameters. These are the parameters that tune a data
modeling technique. The MLR method has no such parame-
ters. The linear SVR method has two such parameters: ε and
C. Epsilon controls the flatness of the resulting data model,
whereas C controls the cost of a prediction error: setting C to
high values will result in fewer prediction errors in the training
data. The RBF SVR method has three model parameters: the
already discussed ε and C and the extra kernel function param-
eter γ, which determines the degree of nonlinearity: setting γ to
high values results in a highly nonlinear data model [39]. The
model parameters can be set using theoretical considerations
that may assume certain properties of the data. The data, how-
ever, are not always perfect: it may contain noise and nonre-
moved trends. Parameter values obtained in this way are thusCritical Care    Vol 11 No 4    Van Looy et al.
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suboptimal. Therefore, in this study, the parameters are set
using theoretical heuristics after which this initial setting is
fine-tuned using pattern search [40]. To validate a specific
parameter selection in linear SVR and RBF SVR, again fivefold
cross-validation was used.
Statistical analysis
Statistical analysis was carried out with SPSS 12.0. Results
are reported as percentages, means, minimums and maxi-
mums, ranges, and SDs (as appropriate). A fivefold cross-val-
idation algorithm was applied for validation of the prediction
results. The correlation between measured and predicted tac-
rolimus blood concentrations was analyzed with a Spearman
rank correlation coefficient. Differences between linear SVR,
RBF SVR, and MLR were analyzed with the Friedman test and
Wilcoxon signed rank test. A Bonferroni adjustment was per-
formed for multiple testing. A Bland-Altman plot was used to
illustrate significant differences between the three compared
methods. Absolute difference as well as signed difference
were studied. Mean absolute difference is the absolute differ-
ence between predicted and measured values, without its
sign, and is an indication of the magnitude of the error,
whereas mean signed difference indicates whether a model
tends to predict higher or lower values than the measured
value. The significance level was set at α = 0.05.
Results
Of the total study population, 58% (29/50) were male, mean
age was 54 years (range 22 to 70), and mean weight was 79
kg. Table 1 gives a summary of the mean absolute differences
between measured and predicted tacrolimus concentrations
for the three models. In the distribution of the prediction errors
made by the three methods, it has to be noted that the MLR
model has the largest number of outliers (Figure 2). Figures 3
to 5 demonstrate the correlation between the observed tac-
rolimus blood concentration and the predicted blood concen-
tration for linear SVR (Figure 3), RBF SVR (Figure 4), and MLR
(Figure 5). These findings were corroborated by the Spearman
rank correlation coefficients, which indicated good correla-
tions for the three methods between the measured and the
predicted blood concentrations: 0.762, 0.753, and 0.742 for
linear SVR, RBF SVR, and MLR, respectively. Mean absolute
difference between measured and predicted blood concentra-
tions was smallest when using linear SVR: this difference
between linear SVR and MLR was statistically significant (p <
0.001). Also, when mean signed differences were analyzed,
the same significantly better results were observed in linear
SVR in comparison with MLR. Even after post hoc analyses (α/
3 for multiple testing, thus significance when p < 0.017), the
significant difference between linear SVR and MLR remained
valid. A Bland-Altman plot (Figure 6) outlines the difference
between linear SVR and MLR.
Discussion
Linear SVR for prediction of tacrolimus blood concentration
resulted in a lower mean absolute error in comparison with the
MLR model (Table 1). Incorporating nonlinearity in the predic-
tor, however, by using a nonlinear kernel function, resulted in a
prediction accuracy that was slightly less than in linear SVR,
but this prediction still outweighed the accuracy of the MLR
model. It is remarkable that this result was obtained using
much fewer variables: only 2 input variables were used instead
of 15 and 16 variables by the linear methods. Apparently,
these 2 input variables contained more information in a nonlin-
ear way than the other 15 or 16 contained in a linear way.
When a linear method (linear SVR or MLR) was examined with
only the 2 input variables used by the nonlinear RBF SVR
model, the obtained prediction accuracy was lower than when
using the nonlinear RBF SVR method. However, the added
prediction strength of the extra 13 or 14 input variables in the
linear SVR and MLR methods, respectively, is rather small. The
nonlinear RBF SVR method is able to extract this extra infor-
mation from only 2 input variables.
It is worth noting that in each of the three prediction models,
the tacrolimus blood concentration on day 1 is incorporated,
along with other variables. Obviously, the tacrolimus concen-
tration on day 1 on its own already contains a lot of information
Table 1
Predicted tacrolimus blood concentration and mean absolute difference between real and predicted tacrolimus blood 
concentrations
Mean (ng/ml) Standard deviation (ng/ml) Minimum (ng/ml) Maximum (ng/ml)
Predicted level linear SVR 10.4 4.2 1.6 34.0
Mean absolute difference 2.31 2.47 0.0 19.6
Predicted level RBF SVR 10.4 4.2 1.4 35.3
Mean absolute difference 2.38 2.49 0.0 19.4
Predicted level MLR 10.8 5.5 3.0 63.7
Mean absolute difference 2.73 3.79 0.0 54.4
MLR, multiple linear regression; RBF SVR, radial basis function support vector regression (nonlinear support vector regression); SVR, support 
vector regression.Available online http://ccforum.com/content/11/4/R83
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about the level to be predicted. To verify the added value of
incorporating this extra variable (tacrolimus dose on day 1), an
RBF SVR model using only the previous tacrolimus blood con-
centration was constructed and evaluated using fivefold
cross-validation. This model yielded a mean absolute error of
3.23 ng/ml (SD 3.12) and a maximum error of 26.33 ng/ml,
indicating that adding the last evening dose of tacrolimus
improves performance drastically. Moreover, it should be
mentioned that in the linear kernel model a moderate amount
of collinearity between the input variables was present (UR on
2 consecutive days, tacrolimus dose on 2 consecutive days)
and that collinearity was not present between the two input
variables of the RBF SVR model. In the MLR model, there was
no problem of multicollinearity after the variable selection
phase. It will be very interesting to see whether the results of
this SVR model will be corroborated by similar results after
testing this new technology on large multicentered ICU data-
bases in future research.
This is the first report in which tacrolimus concentration is
modeled by SVR, but a few other studies have already
Figure 2
Outliers for the prediction of the tacrolimus blood concentration for the  three models Outliers for the prediction of the tacrolimus blood concentration for the 
three models. MLR, multiple linear regression; RBF SVR, radial basis 
function support vector regression (nonlinear support vector regres-
sion); SVR, support vector regression. *'s represent extreme values 
(values more extreme than 3*IQR).
Figure 3
Correlation of real and predicted tacrolimus blood concentrations for  the linear support vector regression model Correlation of real and predicted tacrolimus blood concentrations for 
the linear support vector regression model.
Figure 4
Correlation of real and predicted tacrolimus blood concentrations for  the radial basis function support vector regression model Correlation of real and predicted tacrolimus blood concentrations for 
the radial basis function support vector regression model.
Figure 5
Correlation of real and predicted tacrolimus blood concentrations for  the multiple linear regression model Correlation of real and predicted tacrolimus blood concentrations for 
the multiple linear regression model.Critical Care    Vol 11 No 4    Van Looy et al.
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performed prediction of tacrolimus concentration using other
AI techniques. Chen and colleagues [22] reported the use of
a neural network and a genetic algorithm to predict the tac-
rolimus blood concentration. This neural network algorithm
resulted in an average difference of the observed and pre-
dicted tacrolimus concentrations of 1.74 ng/ml with a range
from 0.08 to 5.26 ng/ml. Bayesian forecasting as well has
been applied in modeling tacrolimus concentrations. Fukudo
and colleagues [41] demonstrated that Bayesian prediction of
tacrolimus concentrations on the basis of previously acquired
population-based pharmacokinetic data in adult patients
receiving living-donor liver transplantation was possible within
a certain timeframe after liver transplantation. However, a
study by Willis and colleagues [42], using a population phar-
macokinetic model based on Bayesian forecasting and
adapted for individual pharmacokinetic, demographic, and
covariate data, resulted in predictions that were too imprecise.
In future research, the SVR-based model will be adapted to
predict the tacrolimus dose to be given to ICU patients to
obtain a predefined window of tacrolimus concentrations.
Afterward, a randomized controlled trial will compare the accu-
racy of intensivists versus this SVR model in daily clinical
practice.
Conclusion
Results demonstrate a statistically significant superiority of lin-
ear SVR in comparison with MLR as well as a trend toward
superiority of nonlinear SVR in comparison with MLR for the
prediction of tacrolimus blood concentration in post-liver
transplantation patients during ICU stay. The accuracies were
all within clinically acceptable ranges. Moreover, nonlinear
SVR required only two variables to make the tacrolimus blood
concentration predictions. SVM technology has promising
possibilities as a clinical decision agent in the ICU
environment.
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